Techne Adds Ubiquitin Research Products
Founded in 1997 and based in Cambridge, Massachusetts, Boston Biochem offers more than 800 ubiquitin-related products. Francesco Melandri, the firm’s founder and president, will join Techne.
Minneapolis, MN 4/4/11—Techne’s R&D Systems division has acquired the assets of Boston Biochem and its European distributor for an undisclosed amount. A developer and manufacturer of ubiquitin-related research products, Boston Biochem had 2010 sales of $2.5 million. The acquisitions are expected to be dilutive to Techne’s fiscal 2012 net earnings by less than $0.02 per share.
< Previous Article | Next Article >

